[{"id":"f85a2e46-4b8c-4129-98ae-6b4b88a3c625","acronym":"","url":"https://clinicaltrials.gov/study/NCT02296879","created_at":"2021-01-18T10:49:46.130Z","updated_at":"2024-07-02T16:37:14.772Z","phase":"Phase 1","brief_title":"A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types","source_id_and_acronym":"NCT02296879","lead_sponsor":"Young Suk Park","biomarkers":" MET","pipe":" | ","alterations":" MET expression","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SAIT301"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 01/20/2015","start_date":" 01/20/2015","primary_txt":" Primary completion: 03/15/2017","primary_completion_date":" 03/15/2017","study_txt":" Completion: 06/20/2017","study_completion_date":" 06/20/2017","last_update_posted":"2018-01-17"}]